Jürgen Veeck
Jürgen Veeck
Group Leader
Verified email at
Cited by
Cited by
Analysis of DNA methylation in cancer: location revisited
A Koch, SC Joosten, Z Feng, TC de Ruijter, MX Draht, V Melotte, ...
Nature reviews Clinical oncology 15 (7), 459-466, 2018
Characteristics of triple-negative breast cancer
TC de Ruijter, J Veeck, JPJ de Hoon, M van Engeland, VC Tjan-Heijnen
Journal of cancer research and clinical oncology 137, 183-192, 2011
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J Veeck, D Niederacher, H An, E Klopocki, F Wiesmann, B Betz, O Galm, ...
Oncogene 25 (24), 3479-3488, 2006
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis
A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ...
BMC cancer 8, 1-15, 2008
Breast cancer epigenetics: from DNA methylation to microRNAs
J Veeck, M Esteller
Journal of mammary gland biology and neoplasia 15, 5-17, 2010
Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3
J Veeck, E Dahl
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1825 (1), 18-28, 2012
BRCA1 CpG island hypermethylation predicts sensitivity to poly (adenosine diphosphate)-ribose polymerase inhibitorsBRCA1 CpG island hypermethylation predicts sensitivity to …
J Veeck, S Ropero, F Setien, E Gonzalez-Suarez, A Osorio, J Benitez, ...
Journal of Clinical Oncology, 2010, vol. 28, num. 29, p. e563-e564, 2010
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
N Bektas, A Haaf, J Veeck, PJ Wild, J Lüscher-Firzlaff, A Hartmann, ...
BMC cancer 8, 1-9, 2008
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
V Kloten, B Becker, K Winner, MG Schrauder, PA Fasching, T Anzeneder, ...
Breast Cancer Research 15, 1-11, 2013
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E Dahl, F Wiesmann, M Woenckhaus, R Stoehr, PJ Wild, J Veeck, ...
Oncogene 26 (38), 5680-5691, 2007
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
J Veeck, PJ Wild, T Fuchs, PJ Schüffler, A Hartmann, R Knüchel, E Dahl
BMC cancer 9, 1-13, 2009
Epigenetic inactivation of the secreted frizzled-related protein-5 ( SFRP5 ) gene in human breast cancer is associated with unfavorable prognosis
J Veeck, C Geisler, E Noetzel, S Alkaya, A Hartmann, R Knüchel, E Dahl
Carcinogenesis 29 (5), 991-998, 2008
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
N Bektas, E Noetzel, J Veeck, MF Press, G Kristiansen, A Naami, ...
Breast Cancer Research 10, 1-12, 2008
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in …
J Veeck, N Bektas, A Hartmann, G Kristiansen, U Heindrichs, R Knüchel, ...
Breast Cancer Research 10, 1-11, 2008
Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives
SC Joosten, L Hamming, PM Soetekouw, MJ Aarts, J Veeck, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1855 (1), 1-16, 2015
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
J Veeck, E Noetzel, N Bektas, E Jost, A Hartmann, R Knüchel, E Dahl
Molecular Cancer 7, 1-19, 2008
Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune
K van den Hurk, HEC Niessen, J Veeck, JJ van den Oord, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (1), 89-102, 2012
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation
J Veeck, M Chorovicer, A Naami, E Breuer, M Zafrakas, N Bektas, M Dürst, ...
Oncogene 27 (6), 865-876, 2008
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
RD Brandão, J Veeck, KK Van de Vijver, P Lindsey, B De Vries, ...
Breast cancer research 15, 1-12, 2013
Promoter methylation-associated loss of ID4expression is a marker of tumour recurrence in human breast cancer
E Noetzel, J Veeck, D Niederacher, O Galm, F Horn, A Hartmann, ...
BMC cancer 8, 1-11, 2008
The system can't perform the operation now. Try again later.
Articles 1–20